|
|
||||||||
Brookhaven National Laboratory, Upton, New York
Correspondence: For reprints contact: David Vartsky, Medical Research Ctr., Medical Dept., Brookhaven National Laboratory, Upton, NY 11973.
ABSTRACT
A method for the in vivo determination of body nitrogen by prompt gamma photons from neutron capture is described. An 85-Ci 238Pu-Be source provides the neutrons. The gamma detection system consists of two 15.24 x 15.24 cm Nal(TI) detectors placed above the patient. Absolute value of body nitrogen is determined using body hydrogen as an internal standard. The reproducibility of the method is ±3 % for a body dose of 26 mrem.
This article has been cited by other articles:
![]() |
L.-L. Norrman, G. Johannsson, K. S. Sunnerhagen, and J. Svensson Baseline Characteristics and the Effects of Two Years of Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency Previously Treated for Acromegaly J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2531 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, K. Stibrant Sunnerhagen, and G. Johannsson Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2061 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gotherstrom, J. Svensson, J. Koranyi, M. Alpsten, I. Bosaus, B.-A. Bengtsson, and G. Johannsson A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4657 - 4665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koranyi, J. Svensson, G. Gotherstrom, K. S. Sunnerhagen, B.-A. Bengtsson, and G. Johannsson Baseline Characteristics and the Effects of Five Years of GH Replacement Therapy in Adults with GH Deficiency of Childhood or Adulthood Onset: A Comparative, Prospective Study J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4693 - 4699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, L. Lönn, J.-O. Jansson, G. Murphy, D. Wyss, D. Krupa, K. Cerchio, W. Polvino, B. Gertz, I. Boseaus, et al. Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 362 - 369. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |